ICD-10 Coding for Prostate Cancer with Metastasis(C78.00, C79.51, C79.51B)
Learn about ICD-10 coding for prostate cancer with metastasis, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Prostate Cancer with Metastasis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C61 | Malignant neoplasm of prostate | Use when prostate cancer is confirmed as the primary site. |
|
| C79.51 | Secondary malignant neoplasm of bone | Use when bone metastasis from prostate cancer is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutProstate Cancer with Metastasis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Prostate Cancer with Metastasis.
Omitting metastatic site details
Impact
Clinical: Inaccurate treatment planning, Regulatory: Non-compliance with coding standards, Financial: Potential underpayment due to incorrect DRG
Mitigation
Thorough review of imaging reports, Regular coding audits
Using 'metastatic bone cancer' without specifying primary site
Impact
Reimbursement: Incorrect DRG assignment leading to potential underpayment., Compliance: Increased risk of audit due to unspecified primary site., Data Quality: Inaccurate cancer registry data.
Mitigation
Query provider to confirm primary site as prostate.
Unspecified primary site
Impact
High risk of audit if primary site is not documented.
Mitigation
Ensure all clinical notes specify primary and secondary sites.